organizational team: info@hodgkinsymposium.org

The meeting aims at a comprehensive overview on all aspects of Hodgkin lymphoma including discussing the most recent controversies in first-line treatment, the problematic treatment of elderly patients and the perspective with newly developed targeted drugs. All major aspects of biology, molecular pathology, staging, treatment and survivorship will be covered. Satellite symposia and scientific workshops will complement the program.